Sino Biopharmaceutical Overview

Sino Biopharmaceutical Other Income Expense Net

Other Income/Expense Net for SBHMY.

Quarterly Other Income/Expense

$1.10B

↑ 8569.72% YoY

As of Jun 30, 2025

Annual Other Income/Expense (TTM)

$1.19B

↑ 3095.23% YoY

Trailing 12 months ending Jun 30, 2025

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin